REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

PATENDULA 2000 Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: PATENDULA 2000 Bt. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

PATENDULA 2000 Bt. is an enterprise in Hungary, with the main office in Szerencs. It operates in the Pharmacies and Drug Stores industry. PATENDULA 2000 Bt. was incorporated on August 16, 1999. It currently has a total number of 8 (2024) employees. In 2024, the company reported a net sales revenue increase of 18.53%. Its’ total assets recorded a growth of 12.26%. PATENDULA 2000 Bt.’s net profit margin decreased by 1.74% in 2024.

Headquarters
Rakoczi u. 102.
Szerencs; Borsod-Abauj-Zemplen; Postal Code: 3900

Contact Details: Purchase the PATENDULA 2000 Bt. report to view the information.

Website: http://www.albapatika.t-online.hu

Basic Information
Total Employees:
Purchase the PATENDULA 2000 Bt. report to view the information.
Registered Capital:
Purchase the PATENDULA 2000 Bt. report to view the information.
Financial Auditors:
Purchase the PATENDULA 2000 Bt. report to view the information.
Incorporation Date:
August 16, 1999
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Szent Mihaly Patika Bt.
WIELAND PATIKA Bt.
Company Performance
Financial values in the chart are available after PATENDULA 2000 Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
18.53%▲
Total operating revenue
17.05%▲
Operating profit (EBIT)
34.57%▲
EBITDA
29.59%▲
Net Profit (Loss) for the Period
-0.16%▼
Total assets
12.26%▲
Total equity
-27.72%▼
Operating Profit Margin (ROS)
1.25%▲
Net Profit Margin
-1.74%▼
Return on Equity (ROE)
11.64%▲
Quick Ratio
-1.21%▼
Cash Ratio
-0.77%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo